GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aveanna Healthcare Holdings Inc (NAS:AVAH) » Definitions » EBITDA

Aveanna Healthcare Holdings (Aveanna Healthcare Holdings) EBITDA : $42 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Aveanna Healthcare Holdings EBITDA?

Aveanna Healthcare Holdings's EBITDA for the three months ended in Dec. 2023 was $14 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $42 Mil.

During the past 3 years, the average EBITDA Growth Rate was -13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 6 years, the highest 3-Year average EBITDA Growth Rate of Aveanna Healthcare Holdings was -13.90% per year. The lowest was -13.90% per year. And the median was -13.90% per year.

Aveanna Healthcare Holdings's EBITDA per Share for the three months ended in Dec. 2023 was $0.07. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.22.

During the past 3 years, the average EBITDA per Share Growth Rate was -15.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 6 years, the highest 3-Year average EBITDA per Share Growth Rate of Aveanna Healthcare Holdings was -15.50% per year. The lowest was -15.50% per year. And the median was -15.50% per year.


Aveanna Healthcare Holdings EBITDA Historical Data

The historical data trend for Aveanna Healthcare Holdings's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aveanna Healthcare Holdings EBITDA Chart

Aveanna Healthcare Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA
Get a 7-Day Free Trial 44.28 61.47 -17.96 -525.06 39.17

Aveanna Healthcare Holdings Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -198.41 12.38 70.20 -54.88 14.03

Competitive Comparison of Aveanna Healthcare Holdings's EBITDA

For the Medical Care Facilities subindustry, Aveanna Healthcare Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aveanna Healthcare Holdings's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aveanna Healthcare Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Aveanna Healthcare Holdings's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Aveanna Healthcare Holdings's EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Aveanna Healthcare Holdings's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2023, Aveanna Healthcare Holdings's EBITDA was $39 Mil.

Aveanna Healthcare Holdings's EBITDA for the quarter that ended in Dec. 2023 is calculated as

Aveanna Healthcare Holdings's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2023, Aveanna Healthcare Holdings's EBITDA was $14 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Aveanna Healthcare Holdings  (NAS:AVAH) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Aveanna Healthcare Holdings EBITDA Related Terms

Thank you for viewing the detailed overview of Aveanna Healthcare Holdings's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Aveanna Healthcare Holdings (Aveanna Healthcare Holdings) Business Description

Traded in Other Exchanges
N/A
Address
400 Interstate North Parkway SE, Suite 1600, Atlanta, GA, USA, 30339
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. HHH segment provides home health, hospice, and specialty program services to elderly populations seeking compassionate care and assistance with activities of daily living in the home. MS segment provides needed supplies to patients requiring enteral nutrition services or respiratory care.
Executives
Deborah Stewart officer: SVP, Chief Accounting Officer 400 INTERSTATE NORTH PARKWAY SE, ATLANTA GA 30339
Matthew Buckhalter officer: See Remarks 400 INTERSTATE NORTH PARKWAY SE, SUITE 1600, ATLANTA GA 30339
Victor F Ganzi director
David Afshar officer: Chief Financial Officer C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE STE 1600, ATLANTA GA 30339
Patrick A. Cunningham officer: Chief Compliance Officer C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE STE 1600, ATLANTA GA 30339
Edwin C. Reisz officer: Chief Administrative Officer C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE STE 1600, ATLANTA GA 30339
Jeff Shaner officer: Chief Operating Officer 3350 RIVERWOOD PARKWAY SUITE 1400, ATLANTA GA 30339
Tony Strange director, officer: Chief Executive Officer 3 HUNTINGTON QUADRANGLE 2S, MELVILLE NY 11747
Rodney D Windley director, officer: Executive Chairman 3 HUNTINGTON QUADRANGLE 2S, MELVILLE NY 11747
Steven E Rodgers director
Erica Schwartz director 400 INTERSTATE N. PARKWAY SE, SUITE 1600, C/O AVEANNA HEALTHCARE HOLDINGS INC., ATLANTA GA 30339
Bcip Associates Iv-b (us), L.p. 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Whitney Strategic Partners Vii, L.p. 10 percent owner 130 MAIN STREET, NEW CANAAN CT 06840
Bcip T Associates Iv-b (us), L.p. 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bcip T Associates Iv (us), L.p. 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116

Aveanna Healthcare Holdings (Aveanna Healthcare Holdings) Headlines